Literature DB >> 23880518

E2f6-mediated repression of the meiotic Stag3 and Smc1β genes during early embryonic development requires Ezh2 and not the de novo methyltransferase Dnmt3b.

Milena Leseva1, Katherine E Santostefano, Amy L Rosenbluth, Takashi Hamazaki, Naohiro Terada.   

Abstract

The E2f6 transcriptional repressor is an E2F-family member essential for the silencing of a group of meiosis-specific genes in somatic tissues. Although E2f6 has been shown to associate with both polycomb repressive complexes (PRC) and the methyltransferase Dnmt3b, the cross-talk between these repressive machineries during E2f6-mediated gene silencing has not been clearly demonstrated yet. In particular, it remains largely undetermined when and how E2f6 establishes repression of meiotic genes during embryonic development. We demonstrate here that the inactivation of a group of E2f6 targeted genes, including Stag3 and Smc1β, first occurs at the transition from mouse embryonic stem cells (ESCs) to epiblast stem cells (EpiSCs), which represent pre- and post-implantation stages, respectively. This process was accompanied by de novo methylation of their promoters. Of interest, despite a clear difference in DNA methylation status, E2f6 was similarly bound to the proximal promoter regions both in ESCs and EpiSCs. Neither E2f6 nor Dnmt3b overexpression in ESCs decreased meiotic gene expression or increased DNA methylation, indicating that additional factors are required for E2f6-mediated repression during the transition. When the SET domain of Ezh2, a core subunit of the PRC2 complex, was deleted, however, repression of Stag3 and Smc1β during embryoid body differentiation was largely impaired, indicating that the event required the enzymatic activity of Ezh2. In addition, repression of Stag3 and Smc1β occurred in the absence of Dnmt3b. The data presented here suggest a primary role of PRC2 in E2f6-mediated gene silencing of the meiotic genes.

Entities:  

Keywords:  DNA methylation; E2f6; Ezh2; embryonic development; germline genes; stem cells; transcriptional silencing

Mesh:

Substances:

Year:  2013        PMID: 23880518      PMCID: PMC3883790          DOI: 10.4161/epi.25522

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  29 in total

1.  A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells.

Authors:  Hidesato Ogawa; Kei-Ichiro Ishiguro; Stefan Gaubatz; David M Livingston; Yoshihiro Nakatani
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

2.  A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner.

Authors:  Claire Attwooll; Sergio Oddi; Peter Cartwright; Elena Prosperini; Karl Agger; Peter Steensgaard; Christian Wagener; Claude Sardet; M Cristina Moroni; Kristian Helin
Journal:  J Biol Chem       Date:  2004-11-08       Impact factor: 5.157

3.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

4.  Comprehensive analysis of CpG islands in human chromosomes 21 and 22.

Authors:  Daiya Takai; Peter A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

5.  E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.

Authors:  P Cartwright; H Müller; C Wagener; K Holm; K Helin
Journal:  Oncogene       Date:  1998-08-06       Impact factor: 9.867

6.  Homeotic transformations of the axial skeleton that accompany a targeted deletion of E2f6.

Authors:  Jörg Storre; Hans-Peter Elsässer; Miriam Fuchs; Diana Ullmann; David M Livingston; Stefan Gaubatz
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

7.  Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells.

Authors:  Melany Jackson; Anna Krassowska; Nick Gilbert; Timothy Chevassut; Lesley Forrester; John Ansell; Bernard Ramsahoye
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

8.  Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement.

Authors:  I-Hsin Su; Ashwin Basavaraj; Andrew N Krutchinsky; Oliver Hobert; Axel Ullrich; Brian T Chait; Alexander Tarakhovsky
Journal:  Nat Immunol       Date:  2002-12-23       Impact factor: 25.606

Review 9.  Intercellular interactions, position, and polarity in establishing blastocyst cell lineages and embryonic axes.

Authors:  Robert O Stephenson; Janet Rossant; Patrick P L Tam
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

10.  The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex.

Authors:  J M Trimarchi; B Fairchild; J Wen; J A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

View more
  8 in total

1.  EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression.

Authors:  Coralie Drelon; Annabel Berthon; Mickael Mathieu; Bruno Ragazzon; Rork Kuick; Houda Tabbal; Amandine Septier; Stéphanie Rodriguez; Marie Batisse-Lignier; Isabelle Sahut-Barnola; Typhanie Dumontet; Jean-Christophe Pointud; Anne-Marie Lefrançois-Martinez; Silvère Baron; Thomas J Giordano; Jérôme Bertherat; Antoine Martinez; Pierre Val
Journal:  Hum Mol Genet       Date:  2016-05-05       Impact factor: 6.150

Review 2.  Soma-to-germline transformation in chromatin-linked neurodevelopmental disorders?

Authors:  Katherine M Bonefas; Shigeki Iwase
Journal:  FEBS J       Date:  2021-10-08       Impact factor: 5.622

3.  Adenine nucleotide translocase 4 is expressed within embryonic ovaries and dispensable during oogenesis.

Authors:  Chae Ho Lim; Jeffrey V Brower; James L Resnick; S Paul Oh; Naohiro Terada
Journal:  Reprod Sci       Date:  2014-07-16       Impact factor: 3.060

4.  From Pioneer to Repressor: Bimodal foxd3 Activity Dynamically Remodels Neural Crest Regulatory Landscape In Vivo.

Authors:  Martyna Lukoseviciute; Daria Gavriouchkina; Ruth M Williams; Tatiana Hochgreb-Hagele; Upeka Senanayake; Vanessa Chong-Morrison; Supat Thongjuea; Emmanouela Repapi; Adam Mead; Tatjana Sauka-Spengler
Journal:  Dev Cell       Date:  2018-12-03       Impact factor: 12.270

5.  Hypoxia-sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR-30a-3p in non-small cell lung cancer.

Authors:  Shuai Yuan; Ying Xiang; Guilu Wang; Meiyu Zhou; Gang Meng; Qingyun Liu; Zeyao Hu; Chengying Li; Weijia Xie; Na Wu; Long Wu; Tongjian Cai; Xiangyu Ma; Yao Zhang; Zubin Yu; Li Bai; Yafei Li
Journal:  Mol Oncol       Date:  2019-01-30       Impact factor: 6.603

6.  E2F6 initiates stable epigenetic silencing of germline genes during embryonic development.

Authors:  Thomas Dahlet; Matthias Truss; Ute Frede; Hala Al Adhami; Anaïs F Bardet; Michael Dumas; Judith Vallet; Johana Chicher; Philippe Hammann; Sarah Kottnik; Peter Hansen; Uschi Luz; Gonzalo Alvarez; Ghislain Auclair; Jochen Hecht; Peter N Robinson; Christian Hagemeier; Michael Weber
Journal:  Nat Commun       Date:  2021-06-11       Impact factor: 14.919

7.  Regulation and Role of EZH2 in Cancer.

Authors:  Hirohito Yamaguchi; Mien-Chie Hung
Journal:  Cancer Res Treat       Date:  2014-07-15       Impact factor: 4.679

8.  The polycomb group protein EZH2 induces epithelial-mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter.

Authors:  Lu Gan; Midie Xu; Ruixi Hua; Cong Tan; Jieyun Zhang; Yiwei Gong; Zhenhua Wu; Weiwei Weng; Weiqi Sheng; Weijian Guo
Journal:  J Hematol Oncol       Date:  2018-01-15       Impact factor: 17.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.